AU5283890A - Fibroblast growth factor (fgf)-based stabilized compositions - Google Patents

Fibroblast growth factor (fgf)-based stabilized compositions

Info

Publication number
AU5283890A
AU5283890A AU52838/90A AU5283890A AU5283890A AU 5283890 A AU5283890 A AU 5283890A AU 52838/90 A AU52838/90 A AU 52838/90A AU 5283890 A AU5283890 A AU 5283890A AU 5283890 A AU5283890 A AU 5283890A
Authority
AU
Australia
Prior art keywords
fgf
growth factor
fibroblast growth
stabilized compositions
tissular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52838/90A
Inventor
Denis Barritault
Jean-Pierre Caruelle
Jose Courty
Jacqueline Jozefonvicz
Faouzi Slaoui
Michele Tardieu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Therapeutiques Subtitutives Groupement dInteret Public
Original Assignee
Therapeutiques Subtitutives Groupement dInteret Public
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9379523&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU5283890(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Therapeutiques Subtitutives Groupement dInteret Public filed Critical Therapeutiques Subtitutives Groupement dInteret Public
Publication of AU5283890A publication Critical patent/AU5283890A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Agents having a cellular and tissular regenerating activity consisting of functionalized substituted dextrans, stabilized compositions containing said agents associated with at least one fibroblast growth factor (FGFs) such as a FGF acid and/or a basic FGF and/or a derivative and/or an analogue and/or a fragment of these disclosing a biological activity and their $i(in vitro) applications such as storing FGFs and cellular cultures and $i(in vivo) applications as a therapeutic agent, in particular for healing and tissular regeneration or as a cosmetic agent.
AU52838/90A 1989-03-09 1990-03-09 Fibroblast growth factor (fgf)-based stabilized compositions Abandoned AU5283890A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8903086A FR2644066B1 (en) 1989-03-09 1989-03-09 STABILIZED COMPOSITIONS COMPRISING FGFS, PROCESS FOR OBTAINING THEM AND THERAPEUTIC, SURGICAL AND COSMETOLOGICAL APPLICATIONS
FR8903086 1989-03-09

Publications (1)

Publication Number Publication Date
AU5283890A true AU5283890A (en) 1990-10-09

Family

ID=9379523

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52838/90A Abandoned AU5283890A (en) 1989-03-09 1990-03-09 Fibroblast growth factor (fgf)-based stabilized compositions

Country Status (10)

Country Link
EP (1) EP0462194B1 (en)
JP (1) JP3236916B2 (en)
AT (1) ATE106743T1 (en)
AU (1) AU5283890A (en)
CA (1) CA2048638C (en)
DE (1) DE69009748T2 (en)
DK (1) DK0462194T3 (en)
ES (1) ES2057544T3 (en)
FR (1) FR2644066B1 (en)
WO (1) WO1990010456A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202311A (en) * 1988-08-19 1993-04-13 Children's Medical Center Corporation Stabilized fgf composition
US5482929A (en) * 1991-12-26 1996-01-09 Kaken Pharmaceutical Co., Ltd. Composition of stabilized fibroblast growth factor
FR2718025B1 (en) * 1994-03-30 1996-06-21 Paris Val Marne Universite Medicament and pharmaceutical composition for the treatment of lesions of the nervous system.
FR2718026B1 (en) * 1994-03-30 1997-01-17 Paris Val Marne Universite Medicine and pharmaceutical composition for the treatment of muscles.
FR2718023B1 (en) * 1994-03-30 1996-08-14 Paris Val Marne Universite Medicament and pharmaceutical composition for the treatment of lesions of the digestive tract.
FR2718024B1 (en) * 1994-03-30 1996-06-21 Paris Val Marne Universite Medicine and pharmaceutical composition for the treatment of inflammation.
FR2772382B1 (en) * 1997-12-11 2000-03-03 Solutions DEXTRAN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATIONS AS MEDICINES WITH SPECIFIC BIOLOGICAL ACTION
FR2781485B1 (en) 1998-07-21 2003-08-08 Denis Barritault BIOCOMPATIBLE POLYMERS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM
FR2781375A1 (en) * 1998-07-21 2000-01-28 Denis Barritault Use of (bio)polymer of heparin-binding growth factor protector and potentiator family to prepare medicament for treating and/or preventing fibrosis
WO2000013710A2 (en) * 1998-09-04 2000-03-16 Scios Inc. Hydrogel compositions for the controlled release administration of growth factors
FR2794649B1 (en) * 1999-06-11 2003-04-11 Solutions BIOMATERIAL BASED ON AN INSOLUBILIZED DEXTRAN DERIVATIVE AND A GROWTH FACTOR, METHOD FOR PREPARING SAME AND ITS APPLICATIONS
FR2794976B1 (en) * 1999-06-16 2004-05-07 Solutions PHARMACEUTICAL COMPOSITIONS WITH HEALING OR ANTI-COMPLEMENTARY ACTION COMPRISING A DEXTRANE DERIVATIVE
US8846003B2 (en) 2008-03-27 2014-09-30 Symic Biomedical, Inc. Collagen-binding synthetic peptidoglycans, preparation, and methods of use
KR102006036B1 (en) 2011-05-24 2019-07-31 시믹 아이피, 엘엘씨 Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
EA201591454A1 (en) 2013-03-15 2015-12-30 Симик Биомедикал, Инк. BINDING EXTRAWAL MATRIX SYNTHETIC PEPTIDOGLYCANY
US10772931B2 (en) 2014-04-25 2020-09-15 Purdue Research Foundation Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
US10792106B2 (en) 2016-10-28 2020-10-06 Covidien Lp System for calibrating an electromagnetic navigation system
CN110809478A (en) 2017-07-07 2020-02-18 斯米克Ip有限公司 Synthetic bioconjugates
US11596399B2 (en) 2021-06-23 2023-03-07 Covidien Lp Anvil buttress attachment for surgical stapling apparatus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ235556A (en) * 1986-11-05 1991-06-25 Ethicon Inc Breast milk substitute containing recombinant human egf

Also Published As

Publication number Publication date
EP0462194A1 (en) 1991-12-27
FR2644066B1 (en) 1994-05-13
CA2048638A1 (en) 1990-09-10
JPH04505756A (en) 1992-10-08
WO1990010456A1 (en) 1990-09-20
FR2644066A1 (en) 1990-09-14
CA2048638C (en) 2002-06-11
DE69009748T2 (en) 1994-09-22
DE69009748D1 (en) 1994-07-14
EP0462194B1 (en) 1994-06-08
JP3236916B2 (en) 2001-12-10
DK0462194T3 (en) 1994-09-19
ATE106743T1 (en) 1994-06-15
ES2057544T3 (en) 1994-10-16

Similar Documents

Publication Publication Date Title
AU5283890A (en) Fibroblast growth factor (fgf)-based stabilized compositions
DE3874813T2 (en) COMPOSITION FOR TREATING THE SKIN.
EP2233150A3 (en) Erythropoietin for use in the treatment of wounds or the transplantation of cells
HUT42329A (en) Process for producing compositions for curing wounds
AU3310595A (en) Compositions and methods for identifying biologically active molecules
BRPI9908182C1 (en) matrix protein compositions for wound healing
UA41879C2 (en) Drug for treating diseases affecting motoneurons
HUT63374A (en) Process for producing new benzoic acid derivatives having cardiovascular activity and pharmaceutical compositions comprising such active ingredient
MX9709910A (en) Inhibitors of factor xa.
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
DE69513324T2 (en) L-lysyl-glycyl-L-histidine and corresponding pharmaceutical compositions for wound healing
ATE363909T1 (en) PHARMACEUTICAL COMPOSITIONS WITH WOUND HEALING AND ANTI-COMPLEMENTARY EFFECTS THAT CONTAIN A DEXTRAN DERIVATIVE
WO2003018598A3 (en) Monosaccharide derivatives
EP0588477A3 (en) Medicinal composition comprising tcf-ii
CA2116179A1 (en) Verotoxin pharmaceutical compositions and medical treatments therewith
ES2191825T3 (en) METAL SALTS OF BILIARY ACIDS WITH PHYSIOLOGICAL ACTION AND ITS USE IN THERAPY.
UA27048C2 (en) Medicinal preparation of immunoreplacement activity the basis of cellular suspension and method for treatment of diabetes mellitus by the use of this preparation
UA15363A (en) Composition for treating open wounds
MX9709908A (en) Ketoheterocyclic inhibitors of factor xa.